COMMUNIQUÉS West-GlobeNewswire
-
Lumina Therapy Alliance Expands to the Bay Area with Addition of San Francisco Stress and Anxiety Center, Approaching 400 Clinicians Nationwide
01/04/2026 -
Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines
01/04/2026 -
J-Star Holding Announces Return of Jonathan Chiang as Chief Executive Officer
01/04/2026 -
From The Earth and Illicit Launch Golden Ticket Giveaway This 4/20 Weekend
01/04/2026 -
Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
01/04/2026 -
Extendicare Acquires CBI Home Health
01/04/2026 -
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development
01/04/2026 -
VivoSim Announces Pricing of up to a $4 Million Public Offering
01/04/2026 -
Johns Hopkins Health Plans Sits Down with Dundalk Seniors to Champion Community Connection
01/04/2026 -
Avicanna Reports Full Year 2025 Audited Financial Statements
01/04/2026 -
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client
01/04/2026 -
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
01/04/2026 -
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
01/04/2026 -
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year
01/04/2026 -
A Kaleidoscope Inspires the Foundation for Sarcoidosis “See Sarcoidosis” Global Campaign for Sarcoidosis Awareness Month
01/04/2026 -
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
01/04/2026 -
Vireo Growth Inc. Announces Closing of Acquisition of Eaze Inc.
01/04/2026 -
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
01/04/2026 -
Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment
01/04/2026
Pages